U.S. stock-index futures rose on Wednesday, as Gilead Sciences' (GILD) statement that its experimental antiviral drug remdesivir met the main goal of a trial testing it in COVID-19 patients, outweighed gloomy Q1 GDP data and mixed quarterly earnings.
Global Stocks:
| Index/commodity | Last | Today's Change, points | Today's Change, % |
| Nikkei | - | - | - |
| Hang Seng | 24,643.59 | +67.63 | +0.28% |
| Shanghai | 2,822.44 | +12.42 | +0.44% |
| S&P/ASX | 5,393.40 | +80.30 | +1.51% |
| FTSE | 6,066.37 | +107.87 | +1.81% |
| CAC | 4,612.59 | +42.80 | +0.94% |
| DAX | 10,975.33 | +179.70 | +1.66% |
| Crude oil | $15.01 | | +21.64% |
| Gold | $1,717.20 | | -0.29% |